A Phase Ib Study of Selumetinib in Patients with Previously Treated or Untreated Advanced/Metastatic NSCLC Who are Receiving Standard Chemotherapy Regimens
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 13 Apr 2018
At a glance
- Drugs Selumetinib (Primary) ; Carboplatin; Cisplatin; Paclitaxel; Pemetrexed
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 10 Apr 2018 Planned primary completion date changed from 1 Mar 2018 to 1 Dec 2018.
- 30 Jan 2018 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
- 30 Jan 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Mar 2018.